Pelthos Therapeutics to present at Wells Fargo 2025 Healthcare Conference on Sept 3

Pelthos Therapeutics Inc.

CEO Scott Plesha and CFO Frank Knuettel to present at Wells Fargo Healthcare Conference on Sept 3, 2025 at 1:30 pm ET.
Company to provide pipeline update and discuss commercial launch of ZELSUVMI (berdazimer) for molluscum contagiosum.
Webcast and replay available on company's website for 90 days.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.